Lonza Group (LZAGY)
(Delayed Data from OTC)
$58.32 USD
+0.33 (0.57%)
Updated Jul 23, 2024 03:59 PM ET
2-Buy of 5 2
D Value D Growth C Momentum D VGM
Brokerage Reports
0 items in cart
Lonza Group Ag [LZAGY]
Reports for Purchase
Showing records 21 - 27 ( 27 total )
Company: Lonza Group Ag
Industry: Medical - Products
Changing 125 Years of History -Healthcare Transformation Complete with Specialty Ingredients Sale
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Lonza Group Ag
Industry: Medical - Products
Global Bioproduction Leader Provides Encouraging Industry Outlook - 28% Capex Growth
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Lonza Group Ag
Industry: Medical - Products
Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Lonza Group Ag
Industry: Medical - Products
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Lonza Group Ag
Industry: Medical - Products
Initiating Coverage at Sector Weight: Global Bioproduction Leader
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Lonza Group Ag
Industry: Medical - Products
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Lonza Group Ag
Industry: Medical - Products
ValuEngine Detailed Valuation Report for LZAGY
Provider: ValuEngine, Inc